Fredun Pharmaceuticals Ltd Share Price Today - Fredun Pharmaceuticals Ltd Stock Price Live NSE/BSE

Fredun Pharmaceuticals Ltd

NSE: BSE: 539730

₹1678.55

(-0.73%)

Sun, 15 Mar 2026, 05:58 am

MTF 5xInvest in Fredun Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap9.07B

PE Ratio24.25

Dividend0.04

Health Technology

Pharmaceuticals: Major

24.5K

Fredun Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
876.14
Net Profit
15.62
P/B
2.81
Sector P/E
32.17
P/E
21.57
EV/EBITDA
11.34
Debt/Equity (Industry)
0.25
Interest Cover (Industry)
11.42
ROCE (Industry)
16.55
RONW (Industry)
14.50
ROE
14.34
ROCE
16.95
Debt/Equity
0.88
EPS (TTM)
60.90
Dividend Yield
0.04
Book Value
443.15
Interest Cover
2.57

Analysis

all

Pros

Fredun Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Fredun Pharmaceuticals is profitable, therefore cash runway is not a concern.
Fredun Pharmaceuticals is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 3.3x debt.
Fredun Pharmaceuticals's cash and other short term assets cover its long term commitments.

Cons

Fredun Pharmaceuticals is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
No need to calculate the sustainability of Fredun Pharmaceuticals's dividends as it is not paying a notable one for India.
Fredun Pharmaceuticals is not paying a notable dividend for India, therefore no need to check if the payments are stable.
Fredun Pharmaceuticals's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.75%).
Fredun Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.09%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	43.06	48.93	48.93	48.93	48.93
FII	0.46	0.01	0	0	0
DII	3.48	1.60	1.59	1.59	1.59
Public	53.00	49.45	49.48	49.48	49.48
Government	0	0	0	0	0

Technical Analysis

RSI

49.22

MACD

-4.12

50 DMA

1604.26

200 DMA

1359.03

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2564.15	2128.15	1876.30	1692.15	1440.30	1256.15	820.15
Fibonacci	2128.15	1961.60	1858.70	1692.15	1525.60	1422.70	1256.15
Camarilla	1744.35	1704.38	1664.42	1692.15	1584.48	1544.52	1504.55

Pivots Level: Classic

+872.00

2564.15

+436.00

2128.15

+184.15

1876.30

1692.15

Pivot Point

LTP: 1632.75

-251.85

1440.30

-436

1256.15

-872

820.15

Moving Average

SMAEMA

Period

Value

10-EMA
1634.86
20-EMA
1639.15
30-EMA
1639.45
50-EMA
1634.38
100-EMA
1576.66
200-EMA
1405.90

Announcement Date	Purpose	Action	Ex Date
09 Feb 2026	board-meetings	Quarterly Results
19 Jan 2026	egm
08 Nov 2025	board-meetings	Quarterly Results
27 Sept 2025	egm
15 Sept 2025	agm
23 Aug 2025	dividend	Final Dividend - Rs. - 0.7	23 Sept 2025
31 May 2025	dividend	₹0.70 Dividend /Share	23 Sept 2025
18 Sept 2024	agm
23 Aug 2024	dividend	Final Dividend - Rs. - 0.7	23 Sept 2024
07 May 2024	dividend	₹0.70 Dividend /Share	23 Sept 2024

Fredun Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Cipla Ltd

Divis Laboratories Ltd

Fredun Pharmaceuticals Ltd About

Fredun Pharmaceuticals is dedicated to improving lives of people. Company’s aim is not only profitability but is effective efficiency. With years of experience in manufacturing various pharmaceutical formulations Fredun Pharmaceuticals Ltd has built a good reputation as a reliable and ethical Company having buyers which not only include leading Pharma Companies of India but also across Africa, South East Asia and CIS countries and Latin America.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Daulat N Medhora

Employees

Contact

Website

http://www.fredungroup.com

business@fredungroup.com

Phone

91-22-40318111

Location

26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031

Year	History
1987	Fredun Pharmaceuticals Ltd was incorporated on 08 June.

Client Name	Order Side	QTY	Avg Price	Date
ASHOK JHINGAN	Sell	24000	443.07	14 Sept 2021
ANAND JHINGAN	Sell	24758	422.48	14 Sept 2021
SURINDER GURMUKH DHAUL	Sell	24881	186.19	01 Jul 2020
ZAHEER .	Sell	112025	183.28	01 Jul 2020
ZAHEER .	Buy	112025	186.01	01 Jul 2020
SURINDER GURMUKH DHAUL	Buy	24881	183.48	01 Jul 2020
KAMAL KUMAR JALAN SEC. PVT. LTD	Buy	33872	184.83	01 Jul 2020
KAMAL KUMAR JALAN SEC. PVT. LTD	Sell	33697	187.3	01 Jul 2020
MADHUBALA PARESH TRIVEDI	Sell	15400	142.7	15 Jan 2018

Fredun Pharmaceuticals Ltd News

Fredun Pharmaceuticals Gets Credit Rating Upgrade

Infomerics upgrades Fredun Pharmaceuticals' credit rating to IVR BBB+ (Stable) from IVR BBB for bank facilities worth ₹156.17 crore, reflecting improved operational performance and financial strength.

25 Feb 2026

stocks

Fredun Pharmaceuticals EOGM Results February 2026

Fredun Pharmaceuticals Limited successfully conducted its Extra-Ordinary General Meeting on February 16, 2026, via video conferencing with 42 shareholders attending and unanimously approving the appointment of Mrs. Pooja Narendra Sanghavi as Non-Executive Independent Director.

16 Feb 2026

stocks

Fredun Pharmaceuticals Q3FY26 Monitoring Report Shows Deviations

Care Ratings flags 25-50% deviation range in Fredun Pharmaceuticals' preferential allotment proceeds utilization for Q3FY26, citing improper fund routing and classification issues in Rs. 97.78 crore raised.

14 Feb 2026

co actions results

Fredun Pharmaceuticals Q3FY26 Call on Feb 12

Fredun Pharmaceuticals announces earnings conference call on February 12, 2026 at 12:00 PM to discuss Q3FY26 results for quarter ended December 31, 2025.

09 Feb 2026

co actions results

Fredun Pharmaceuticals Board Meet on Feb 9, 2026

Fredun Pharmaceuticals Limited has scheduled its board meeting for February 9, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window closed until 48 hours post-declaration.

30 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800